國家聯合資源(00254.HK):預計公開發售3月9日完成 繼續停牌
格隆匯3月8日丨國家聯合資源(00254.HK)發佈公吿,公開發售的所有先決條件已獲達成,且公開發售完成預計於2022年3月9日作實。2022年3月4日(星期五)下午四時正(即配售結束日期),配售代理已配售436萬股未獲認購股份。因此,合共約5.29億股未獲承購股份已根據包銷協議的條款由包銷商╱分包銷商及其各自分包銷商以及彼等促成的獨立承配人予以承購。公司股份有關買賣仍然暫停進行及將繼續暫停進行直至另行通知為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.